Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
4,000.00
+275.00 (7.38%)
Nov 2, 2026, 3:30 PM KST
| Market Cap | 93.03B -57.9% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 96,121 |
| Open | 3,725.00 |
| Previous Close | 3,725.00 |
| Day's Range | 3,725.00 - 4,030.00 |
| 52-Week Range | 3,350.00 - 11,520.00 |
| Beta | 0.68 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |